These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22203543)

  • 21. Is PSA testing still useful?
    Mitka M
    JAMA; 2004 Nov; 292(19):2326-7. PubMed ID: 15547145
    [No Abstract]   [Full Text] [Related]  

  • 22. Informed consent for prostate-specific antigen-based screening--European view.
    Ito K; Schrder FH
    Urology; 2003 Jan; 61(1):20-2. PubMed ID: 12559259
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostate cancer: screening approaches.
    Donovan JL; Martin RM; Neal DE; Hamdy FC
    Br J Hosp Med (Lond); 2005 Nov; 66(11):623-6. PubMed ID: 16308948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informed consent for prostate-specific antigen testing.
    Gann PH
    Urology; 2003 Jan; 61(1):5-6. PubMed ID: 12559253
    [No Abstract]   [Full Text] [Related]  

  • 25. Reliability and validity of prostate-specific antigen.
    Hakama M; Auvinen A
    JAMA; 2003 Oct; 290(13):1705; author reply 1705-6. PubMed ID: 14519697
    [No Abstract]   [Full Text] [Related]  

  • 26. Rationale for earlier and less frequent prostate cancer screening.
    Carter HB
    Urology; 2001 Nov; 58(5):639-41. PubMed ID: 11711328
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostate cancer screening.
    Atkins D
    JAMA; 1997 Jan 22-29; 277(4):299-300. PubMed ID: 9002491
    [No Abstract]   [Full Text] [Related]  

  • 28. The story of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; Denis LJ; Roobol M; Nelen V; Auvinen A; Tammela T; Villers A; Rebillard X; Ciatto S; Zappa M; Berenguer A; Paez A; Hugosson J; Lodding P; Recker F; Kwiatkowski M; Kirkels WJ;
    BJU Int; 2003 Dec; 92 Suppl 2():1-13. PubMed ID: 14983946
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of prostate specific antigen in screening and management of clinically localized prostate cancer.
    Guru K; Tewari A; Hemal AK; Wei J; Javidan J; Peabody J; Menon M
    Int Urol Nephrol; 2003; 35(1):107-13. PubMed ID: 14620298
    [No Abstract]   [Full Text] [Related]  

  • 30. The case against.
    Donovan JL; Hamdy FC; Neal DE;
    Ann R Coll Surg Engl; 2005 Mar; 87(2):90-1. PubMed ID: 16790127
    [No Abstract]   [Full Text] [Related]  

  • 31. Mixed response to new PSA screening study.
    Phillips P
    JAMA; 1998 Jul; 280(1):8-9. PubMed ID: 9660345
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening for prostate cancer: the current position.
    Moss SM; Melia J
    Br Med Bull; 1998; 54(4):791-805. PubMed ID: 10367415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of prostatic specific antigen screening in prostatic cancer].
    Allepuz Losa C; Bosque A; Rioja Sanz LA
    Rev Clin Esp; 2000 Jun; 200(6):323-4. PubMed ID: 10953586
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines.
    Carter HB; Pearson JD
    Urology; 1999 Nov; 54(5):780-6. PubMed ID: 10565733
    [No Abstract]   [Full Text] [Related]  

  • 35. Current challenges in cancer screening. Part II. Prostate cancer screening.
    Clarke P
    Dis Mon; 2000 Jun; 46(6):381-404. PubMed ID: 10909860
    [No Abstract]   [Full Text] [Related]  

  • 36. An argument against routine prostate cancer screening.
    Hoffman RM
    Arch Intern Med; 2003 Mar; 163(6):663-5; discussion 665-6. PubMed ID: 12639196
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of prostate cancer. Recent evidence suggests screening may be justified in high risk younger men.
    Foulkes W
    BMJ; 1995 Apr; 310(6987):1139-40. PubMed ID: 7537993
    [No Abstract]   [Full Text] [Related]  

  • 38. The conundrum of prostate cancer.
    Albertsen PC
    Cancer J; 2002; 8(6):432-4. PubMed ID: 12500849
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen.
    Brown M; Feuer E
    Urology; 1997 Feb; 49(2):306-7. PubMed ID: 9037307
    [No Abstract]   [Full Text] [Related]  

  • 40. Urologists present positive evidence for early test.
    Mitka M
    JAMA; 1998 Jul; 280(1):9. PubMed ID: 9660346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.